R87.89Other abnormal findings in specimens from female genital organs

R87.89 is the ICD-10-CM diagnosis code for other abnormal findings in specimens from female genital organs. It belongs to category R87 (abnormal findings in specimens from female genital organs), block R83-R89 (abnormal findings on examination of other body fluids, substances and tissues, without diagnosis) and chapter 18 (symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within R87.8, choose R87.89 (Other abnormal findings in specimens from female genital organs) only when documentation doesn't support a more specific option: high risk human papillomavirus (HPV) DNA test positive from female genital organs (R87.81) and low risk human papillomavirus (HPV) DNA test positive from female genital organs (R87.82).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 947 (Signs and Symptoms with MCC, relative weight 1.261) and DRG 948 (Signs and Symptoms without MCC, relative weight 0.7835), in MDC 23 (Factors Influencing Health Status and Other Contacts with Health Services), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It is on the CMS list of diagnoses consistent only with female patients (the sex-conflict edit itself was retired in FY2025).

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 792.9 (other nonspecific abnormal findings in body substances).